Study Further Demonstrates Envisia Classifier Robustness
Lung Disease News,
Veracyte says new data confirming the analytical validity of its Envisia Genomic Classifier demonstrate its benefits in…
Veracyte says new data confirming the analytical validity of its Envisia Genomic Classifier demonstrate its benefits in…
(NASDAQ: VCYT) announced that data confirming the analytical validity of the company’s Envisia™ Genomic Classifier have been…
SOUTH SAN FRANCISCO, Calif.--(Business Wire)-- Veracyte, Inc. (NASDAQ: VCYT) announced that data confirming the analytical…
Veracyte, Inc. (NASDAQ: VCYT) announced that data confirming the analytical validity of the company’s Envisia™ Genomic…